Publications by Wim Van Criekinge.

2016

Discovery of new methylation markers to improve screening for cervical intraepithelial neoplasia grade 2/3
A. Boers, R. Wang, R. van Leeuwen, H. Klip, G. de Bock, H. Hollema, W. Van Criekinge, T. De Meyer, S. Denil, A. van der Zee, E. Schuuring and G. Wisman
(2016) CLINICAL EPIGENETICS, 8, 29

Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma
R. Wang, R. van Leeuwen, A. Boers, H. Klip, T. De Meyer, R. Steenbergen, W. Van Criekinge, A. van der Zee, E. Schuuring and G. Wisman
(2016) ONCOTARGET, 7,

Dynamic epigenetic changes to VHL occur with sunitinib in metastatic clear cell renal cancer
G. Stewart, T. Powles, C. Van Neste, A. Meynert, F. O'Mahony, A. Laird, D. Deforce, F. Van Nieuwerburgh, G. Trooskens, W. Van Criekinge, T. De Meyer and D. Harrison
(2016) ONCOTARGET, 7,

Forensic Loci Allele Database (FLAD) : automatically generated, permanent identifiers for sequenced forensic alleles
C. Van Neste, W. Van Criekinge, D. Deforce and F. Van Nieuwerburgh
(2016) FORENSIC SCIENCE INTERNATIONAL-GENETICS, 20,

Identification and validation of WISP1 as an epigenetic regulator of metastasis in oral squamous cell carcinoma
M. Clausen, L. Melchers, M. Mastik, L. Slagter-Menkema, H. Groen, B. van der Laan, W. Van Criekinge, T. De Meyer, S. Denil, G. Wisman, J. Roodenburg and E. Schuuring
(2016) GENES CHROMOSOMES & CANCER, 55,

Detection of high-grade prostate cancer using a urinary molecular biomarker-based risk score
L. Van Neste, R. Hendriks, S. Dijkstra, G. Trooskens, E. Cornel, S. Jannink, H. de Jong, D. Hessels, F. Smit, W. Melchers, G. Leyten, T. de Reijke, H. Vergunst, P. Kil, B. Knipscheer, C. Hulsbergen-van de Kaa, P. Mulders, I. van Oort, W. Van Criekinge and J. Schalken
(2016) EUROPEAN UROLOGY, 70,

RAB25 expression is epigenetically downregulated in oral and oropharyngeal squamous cell carcinoma with lymph node metastasis
M. Clausen, L. Melchers, M. Mastik, L. Slagter-Menkema, H. Groen, B. van der Laan, W. Van Criekinge, T. De Meyer, S. Denil, B. van der Vegt, G. Wisman, J. Roodenburg and E. Schuuring
(2016) EPIGENETICS, 11,

Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients
T. Seremet, A. Koch, Y. Jansen, M. Schreuer, S. Wilgenhof, V. Del Marmol, D. Liènard, K. Thielemans, K. Schats, M. Kockx, W. Van Criekinge, P. Coulie, T. De Meyer, N. van Baren and B. Neyns
(2016) JOURNAL OF TRANSLATIONAL MEDICINE, 14, 232

Risk score predicts high-grade prostate cancer in DNA-methylation positive, histopathologically negative biopsies
L. Van Neste, A. Partin, G. Stewart, J. Epstein, D. Harrison and W. Van Criekinge
(2016) PROSTATE, 76,

WRN promoter CpG island hypermethylation does not predict more favorable outcomes for patients with metastatic colorectal cancer treated with irinotecan-based therapy
L. Bosch, Y. Luo, V. Lao, P. Snaebjornsson, G. Trooskens, I. Vlassenbroeck, S. Mongera, W. Tang, P. Welcsh, J. Herman, M. Koopman, I. Nagtegaal, C. Punt, W. Van Criekinge, G. Meijer, R. Monnat,, B. Carvalho and W. Grady
(2016) CLINICAL CANCER RESEARCH, 22,